These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 1832593

  • 1. Dopamine D1 receptor behavioral responsitivity following selective lesions of the striatal patch compartment during development.
    Neal BS, Joyce JN.
    Brain Res Dev Brain Res; 1991 Jun 21; 60(2):105-13. PubMed ID: 1832593
    [Abstract] [Full Text] [Related]

  • 2. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS, Joyce JN.
    Dev Psychobiol; 1998 May 21; 32(4):313-26. PubMed ID: 9589220
    [Abstract] [Full Text] [Related]

  • 3. Neonatal 6-OHDA lesions differentially affect striatal D1 and D2 receptors.
    Neal BS, Joyce JN.
    Synapse; 1992 May 21; 11(1):35-46. PubMed ID: 1351321
    [Abstract] [Full Text] [Related]

  • 4. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 21; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 5. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 21; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 6. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep 21; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 7. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE, Yates TM.
    Neuroscience; 1999 Sep 21; 94(2):505-14. PubMed ID: 10579212
    [Abstract] [Full Text] [Related]

  • 8. The effects of chronic continuous versus intermittent levodopa treatments on striatal and extrastriatal D1 and D2 dopamine receptors and dopamine uptake sites in the 6-hydroxydopamine lesioned rat--an autoradiographic study.
    Gnanalingham KK, Robertson RG.
    Brain Res; 1994 Mar 21; 640(1-2):185-94. PubMed ID: 8004447
    [Abstract] [Full Text] [Related]

  • 9. Postnatal development of striatal dopamine function. II. Effects of neonatal 6-hydroxydopamine treatments on D1 and D2 receptors, adenylate cyclase activity and presynaptic dopamine function.
    Broaddus WC, Bennett JP.
    Brain Res Dev Brain Res; 1990 Mar 01; 52(1-2):273-7. PubMed ID: 2110042
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
    LaHoste GJ, Marshall JF.
    Behav Brain Res; 1990 May 28; 38(3):233-42. PubMed ID: 1973041
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: autoradiographic evidence against the dual mechanism hypothesis.
    LaHoste GJ, Marshall JF.
    Neuroscience; 1991 May 28; 41(2-3):473-81. PubMed ID: 1678501
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour.
    Robertson HA, Peterson MR, Murphy K, Robertson GS.
    Brain Res; 1989 Dec 04; 503(2):346-9. PubMed ID: 2532558
    [Abstract] [Full Text] [Related]

  • 18. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
    Fletcher GH, Starr MS.
    Neuroscience; 1987 Dec 04; 23(3):1001-10. PubMed ID: 2963970
    [Abstract] [Full Text] [Related]

  • 19. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
    Delfs JM, Kelley AE.
    Neuroscience; 1990 Dec 04; 39(1):59-67. PubMed ID: 1982467
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.